Sarah Berhane

8.1k total citations · 3 hit papers
41 papers, 4.2k citations indexed

About

Sarah Berhane is a scholar working on Hepatology, Epidemiology and Cancer Research. According to data from OpenAlex, Sarah Berhane has authored 41 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hepatology, 17 papers in Epidemiology and 8 papers in Cancer Research. Recurrent topics in Sarah Berhane's work include Hepatocellular Carcinoma Treatment and Prognosis (18 papers), Liver Disease Diagnosis and Treatment (15 papers) and Cancer, Lipids, and Metabolism (8 papers). Sarah Berhane is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (18 papers), Liver Disease Diagnosis and Treatment (15 papers) and Cancer, Lipids, and Metabolism (8 papers). Sarah Berhane collaborates with scholars based in United Kingdom, Japan and Hong Kong. Sarah Berhane's co-authors include Philip J. Johnson, Takashi Kumada, Hidenori Toyoda, Toshifumi Tada, Paul B.S. Lai, Mabel Teng, Shinji Satomura, Helen L. Reeves, Chiaki Kagebayashi and Richard Fox and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and Cochrane Database of Systematic Reviews.

In The Last Decade

Sarah Berhane

41 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade

2014 1.8k citations Philip J. Johnson, Sarah Berhane et al. profile →
Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection

2020 827 citations Jacqueline Dinnes, Jonathan J Deeks et al. Cochrane Database of Systematic Reviews profile →
Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection

2018 349 citations Anthony W.H. Chan, Jian‐Hong Zhong et al. Journal of Hepatology profile →

Peers

Countries citing papers authored by Sarah Berhane

Since Specialization

Citations

This map shows the geographic impact of Sarah Berhane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Berhane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Berhane more than expected).

Fields of papers citing papers by Sarah Berhane

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Berhane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Berhane. The network helps show where Sarah Berhane may publish in the future.

Co-authorship network of co-authors of Sarah Berhane

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Berhane. A scholar is included among the top collaborators of Sarah Berhane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Berhane. Sarah Berhane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparing Artificial Intelligence and manual methods in systematic review processes: protocol for a systematic review 2025 ·Journal of Clinical Epidemiology ·(unknown), KM Saif‐Ur‐Rahman, Sarah Berhane, Xiaomei Yao, Kavita Kothari, Petek Eylül Taneri, James Thomas, Declan Devane	2
2	The effect of sample site and collection procedure on identification of SARS-CoV-2 infection 2024 ·Cochrane Database of Systematic Reviews ·Clare Davenport, Ingrid Arévalo-Rodríguez, (unknown), Sarah Berhane, Jacqueline Dinnes, René Spijker, Diana Buitrago‐García, (unknown), Yemisi Takwoingi, Jonathan J Deeks, Devy Emperador, Mariska Leeflang, Ann Van den Bruel, (unknown)	1
3	Accuracy of package inserts of SARS-CoV-2 rapid antigen tests: a secondary analysis of manufacturer versus systematic review data 2023 ·The Lancet Microbe ·Jacob Bigio, Emily MacLean, (unknown), Giorgia Sulis, Mikashmi Kohli, Sarah Berhane, Jacqueline Dinnes, Jonathan J Deeks, Lukas E. Brümmer, Claudia M. Denkinger, Madhukar Pai	6
4	The Impact of Diabetes and Glucose-Lowering Therapies on Hepatocellular Carcinoma Incidence and Overall Survival 2022 ·Clinical Therapeutics ·Theresa Hydes, Daniel J. Cuthbertson, (unknown), Sarah Berhane, Mabel Teng, Anna Skowrońska, Pushpa Singh, (unknown), Abd A. Tahrani, Philip J. Johnson	10
5	Bystander cardiopulmonary resuscitation for paediatric out-of-hospital cardiac arrest in England: An observational registry cohort study 2021 ·Resuscitation ·(unknown), Susan Mallett, Sarah Berhane, Stephen Booth, Claire Hawkes, Gavin D. Perkins, (unknown), Theresa Foster, Barnaby R. Scholefield	8
6	Sorafenib is associated with a reduced rate of tumour growth and liver function deterioration in HCV-induced hepatocellular carcinoma 2021 ·Journal of Hepatology ·Ruwanthi Kolamunnage‐Dona, Sarah Berhane, (unknown), Edward H. Williams, James Tanner, Tobias Janowitz, Matthew Hoare, Philip J. Johnson	13
7	Serum Levels of α-Fetoprotein Increased More Than 10 Years Before Detection of Hepatocellular Carcinoma 2020 ·Clinical Gastroenterology and Hepatology ·David M. Hughes, Sarah Berhane, (unknown), Hidenori Toyoda, Toshifumi Tada, Takashi Kumada, Shinji Satomura, Naoshi Nishida, Masatoshi Kudo, Tōru Kimura, Yukio Osaki, (unknown), Rubén Amorós, Thomas G. Bird, Marta García‐Fiñana, Philip J. Johnson	22
8	Impact of direct‐acting antiviral agents on liver function in patients with chronic hepatitis C virus infection 2020 ·Journal of Viral Hepatitis ·Philip J. Johnson, Sarah Berhane, Alex J Walker, F. Gordon, Stephen Ryder, Stuart McPherson, Aravamuthan Sreedharan, Andrew Ustianowski, Kosh Agarwal, David Mutimer, (unknown), Hidenori Toyoda, William L. Irving	7
9	Information given by websites selling home self-sampling COVID-19 tests: an analysis of accuracy and completeness 2020 ·BMJ Open ·Sian Taylor‐Phillips, Sarah Berhane, Alice Sitch, Karoline Freeman, Malcolm J Price, Clare Davenport, Julia Geppert, Isobel Marion Harris, (unknown), Magdalena Skrybant, Jonathan J Deeks	7
10	Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection breakdown → 2020 ·Cochrane Database of Systematic Reviews ·Jacqueline Dinnes, Jonathan J Deeks, Ada Adriano, Sarah Berhane, Clare Davenport, Sabine Dittrich, Devy Emperador, Yemisi Takwoingi, Jane Cunningham, Sophie Beese, Janine Dretzke, Lavinia Ferrante di Ruffano, Isobel Marion Harris, Malcolm J Price, Sian Taylor‐Phillips, Lotty Hooft, Mariska Leeflang, René Spijker, Ann Van den Bruel, (unknown)	827
11	Validation of a Model for Identification of Patients With Compensated Cirrhosis at High Risk of Decompensation 2019 ·Clinical Gastroenterology and Hepatology ·Indra Neil Guha, Rebecca Harris, Sarah Berhane, (unknown), (unknown), Martin W. James, Alessandro Cucchetti, D. J. Harman, Guruprasad P. Aithal, Omar Elshaarawy, Imam Waked, Stephen Stewart, Philip J. Johnson	42
12	The chances of hepatic resection curing hepatocellular carcinoma 2019 ·Journal of Hepatology ·Alessandro Cucchetti, Jian‐Hong Zhong, Sarah Berhane, Hidenori Toyoda, Keqing Shi, Toshifumi Tada, Charing C. N. Chong, Bang‐De Xiang, Le‐Qun Li, Paul B.S. Lai, Giorgio Ercolani, Vincenzo Mazzaferro, Masatoshi Kudo, Matteo Cescon, Antonio Daniele Pinna, Takashi Kumada, Philip J. Johnson	40
13	Multicentre validation of a clinical prognostic score integrating the systemic inflammatory response to the host for patients treated with curative-intent for colorectal liver metastases: The Liverpool score 2019 ·European Journal of Surgical Oncology ·Aurélien Dupré, Sarah Berhane, Anthony W.H. Chan, Michel Rivoire, Charing C. N. Chong, Paul B.S. Lai, Alessandro Cucchetti, Graeme J. Poston, Hafiz Malik, P. J. Johnson	9
14	Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection breakdown → 2018 ·Journal of Hepatology ·Anthony W.H. Chan, Jian‐Hong Zhong, Sarah Berhane, Hidenori Toyoda, Alessandro Cucchetti, Keqing Shi, Toshifumi Tada, Charing C. N. Chong, Bang‐De Xiang, Le‐Qun Li, Paul B.S. Lai, Vincenzo Mazzaferro, Marta García‐Fiñana, Masatoshi Kudo, Takashi Kumada, Sasan Roayaie, Philip J. Johnson	349
15	Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade 2016 ·British Journal of Cancer ·Hidenori Toyoda, Paul B.S. Lai, James O’Beirne, Charing C. N. Chong, Sarah Berhane, Helen L. Reeves, Derek Manas, Richard Fox, Winnie Yeo, Frankie Mo, Anthony W.H. Chan, Toshifumi Tada, Mercedes Iñarrairaegui, Arndt Vogel, Nóra Schweitzer, Stephen L. Chan, Bruno Sangro, Takashi Kumada, Philip J. Johnson	146
16	Biomarker-based prognosis in hepatocellular carcinoma: validation and extension of the BALAD model 2014 ·British Journal of Cancer ·Richard Fox, Sarah Berhane, Mabel Teng, Trevor F. Cox, Toshifumi Tada, Hidenori Toyoda, Takashi Kumada, Chiaki Kagebayashi, Shinji Satomura, Philip J. Johnson	39
17	The dual-acting chemotherapeutic agent Alchemix induces cell death independently of ATM and p53 2014 ·Oncogene ·(unknown), Tracey Perry, Sarah Berhane, Ceri Oldreive, Anastasia Zlatanou, Luke Williams, Victoria Weston, Tatjana Stanković, Pamela Kearns, Klaus Pors, Roger J.A. Grand, Grant S. Stewart	6
18	International validation of the Chinese University Prognostic Index for staging of hepatocellular carcinoma: a joint United Kingdom and Hong Kong study 2014 ·Chinese Journal of Cancer ·Stephen L. Chan, Philip J. Johnson, Frankie Mo, Sarah Berhane, Mabel Teng, Anthony W.H. Chan, (unknown), Paul B.S. Lai, Simon C.H. Yu, Anthony T.�C. Chan, Winnie Yeo	23
19	Phase I/II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanoma 2011 ·Gene Therapy ·Jane C. Steele, A S Rao, Jerry Marsden, (unknown), Sarah Berhane, Lucinda Billingham, Nicholas A. Graham, Claudia Roberts, Gordon B. Ryan, Hardeep Uppal, Catherine M. Walker, Lawrence S. Young, Neil Steven	39
20	Adenovirus E1A interacts directly with, and regulates the level of expression of, the immunoproteasome component MECL1 2011 ·Virology ·Sarah Berhane, Cristina Aresté, Jailal Ablack, Gordon B. Ryan, David J. Blackbourn, Joe S. Mymryk, Andrew S. Turnell, Jane C. Steele, Roger J.A. Grand	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact